A 17-member group of doctors, public health experts, lawmakers and community activists will guide Gov. Charlie Baker’s administration on how to distribute a coronavirus vaccine — once one is available — equitably, safely and efficiently.
There are currently 11 vaccine candidates in the last phase of clinical trials testing for safety and efficacy, according to the New York Times vaccine tracker. Massachusetts’ own Moderna is currently conducting some of its trials at Brigham & Women’s Hospital in Boston. Moderna and Pfizer are leading the pack, most likely to cross the finish line to a viable vaccine first, experts have said.
The advisory group held its first meeting last week and the governor’s office said its work will build on vaccine planning that has been underway since August.
Members are working closely with leaders from the Department of Public Health and adding to the commonwealth’s state-of-the-art Massachusetts Immunization Information System, which